EC Healthcare Stock Price

EC Healthcare provides medical and healthcare services in Hong Kong, Macau, Mainland China, and Taiwan. It operates through three segments: Medical; Aesthetic Medical and Beauty and Wellness; and Veterinary and Other segments. The company offers medical services, including general and family medicine, musculoskeletal health and pain management, eye care, fertility and women’s health, men’s health, children’s health, digestive health, chronic disease management, Chinese medicine, sports medicine, corporate medicine and work rehabilitation, preventive screening and diagnostic imaging, rehabilitation and homecare, and heart and vascular health, oncology and cancer, and allergies and immunology. It also provides aesthetics and antiaging and wellness services; and veterinary, pet care, and lifestyle services. In addition, the company sells skincare products and beauty products; distributes aesthetic devices and beauty related consumables; leases aesthetic devices; provides cancer diagnostic, hair treatment, dental, quasi-medical, traditional beauty, medical surgery, vaccine, hair, chiropractic, and audio engineering solutions and acoustic technology services; and offers cosmetics product. Further, it is involved in property investment; beauty brand management and cosmetic business development; administrative services; medical imaging; provision of management services; scientific instruments and laboratory solutions; biotechnology; integrated life sciences; genomic data solutions; wellness and lifestyle enhancement services; molecular diagnostics; life science research tools; laboratory testing; multi-channel networking services; marketing; and travel agency services. It offers its products and services under the PRODERMA LAB, Swissline, Suissebeaute, and re:HEALTH brands. The company was formerly known as Union Medical Healthcare Limited and changed its name to EC Healthcare in April 2021. EC Healthcare was founded in 2005 and is headquartered in Quarry Bay, Hong Kong.